Cellebrite (CLBT) insider Marcus Jewell files to sell 1,779 shares

Rhea-AI Filing Summary

Cellebrite DI Ltd. insider plans a small stock sale under Rule 144. Marcus Jewell filed to sell 1,779 ordinary shares, par value NIS 0.00001, through Morgan Stanley Smith Barney LLC on or about 02/12/2026 on Nasdaq, with an aggregate market value of $25,368.54. The filing notes 248,830,759 ordinary shares outstanding.

The shares to be sold come from 4,187 restricted share units that vested under an issuer S‑8 registered employee compensation plan. Over the prior three months, Jewell sold 12,543 and 9,592 ordinary shares on 11/17/2025 and 11/18/2025, generating gross proceeds of $230,372.06 and $174,286.64.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/12/2026 - 04:05 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary shares, par value NIS 0.00001	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 38th Floor New York NY 10004	1779	25368.54	248830759	02/12/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary shares, par value NIS 0.00001	02/12/2026	Restricted Share Units Vested Under an Issuer S-8 Registered Plan	Cellebrite DI Ltd.			4187	02/11/2026	Employee compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Marcus Jewell 94 Shlomo Shmelzer Road Petah Tikva L3 4970602	Ordinary shares, par value NIS 0.00001	11/17/2025	12543	230372.06
Marcus Jewell 94 Shlomo Shmelzer Road Petah Tikva L3 4970602	Ordinary shares, par value NIS 0.00001	11/18/2025	9592	174286.64

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filing by Cellebrite (CLBT) disclose?

The filing discloses that insider Marcus Jewell intends to sell 1,779 Cellebrite ordinary shares under SEC Rule 144. The planned sale has an aggregate market value of $25,368.54 and will be executed through Morgan Stanley Smith Barney LLC on Nasdaq.

How many Cellebrite (CLBT) shares is Marcus Jewell planning to sell?

Marcus Jewell plans to sell 1,779 ordinary shares of Cellebrite DI Ltd. The aggregate market value reported for this proposed transaction is $25,368.54, and the shares are expected to be sold on or about February 12, 2026, through Morgan Stanley Smith Barney LLC.

What is the source of the Cellebrite (CLBT) shares being sold?

The shares come from restricted share units that vested under an issuer S-8 registered employee compensation plan. The filing shows 4,187 ordinary shares were acquired via vested RSUs, with payment dated February 11, 2026, categorized as employee compensation rather than a cash purchase.

On which exchange will the Cellebrite (CLBT) shares be sold and through which broker?

The planned sale will occur on the Nasdaq exchange using broker Morgan Stanley Smith Barney LLC Executive Financial Services. The broker’s address is listed as 1 New York Plaza, 38th Floor, New York, NY 10004, handling the Rule 144 transaction for Marcus Jewell.

How many Cellebrite (CLBT) shares are outstanding according to this filing?

The filing states that 248,830,759 ordinary shares of Cellebrite DI Ltd. are outstanding. This figure provides context for the size of the planned 1,779-share sale, indicating it represents a very small fraction of the company’s total ordinary shares in circulation.

What Cellebrite (CLBT) stock sales has Marcus Jewell made in the past three months?

The filing reports two prior sales in the last three months. On November 17, 2025, he sold 12,543 ordinary shares for gross proceeds of $230,372.06, and on November 18, 2025, he sold 9,592 ordinary shares for gross proceeds of $174,286.64.